Wealthcare Advisory Partners LLC lifted its position in Amgen Inc. (NASDAQ:AMGN – Get Rating) by 9.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,852 shares of the medical research company’s stock after acquiring an additional 762 shares during the period. […]
Northeast Financial Consultants Inc lifted its stake in Amgen Inc. (NASDAQ:AMGN – Get Rating) by 24.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,086 shares of the medical research company’s stock after buying an additional 1,200 shares during the period. Northeast […]
Wealthcare Advisory Partners LLC grew its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Get Rating) by 9.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,852 shares of the medical research company’s stock after buying an additional 762 shares during the quarter. […]
Harfst & Associates Inc. decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Get Rating) by 1.8% in the 4th quarter, HoldingsChannel.com reports. The fund owned 2,503 shares of the medical research company’s stock after selling 47 shares during the quarter. Harfst & Associates Inc.’s holdings in Amgen were worth $657,000 as of its […]
West Michigan Advisors LLC acquired a new position in Amgen Inc. (NASDAQ:AMGN – Get Rating) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 961 shares of the medical research company’s stock, valued at approximately $252,000. Several other hedge funds and other institutional […]